The future of mental health tools are objective, based in biology, and powered by machine learning and genomics

The future of mental health tools are objective, based in biology, and powered by machine learning and genomics

Clinical tools that harness genomics use biology as an objective wayfinding force. Together, let’s increase efficacy and safety, and enable individualized treatments of underlying conditions rather than solely treating symptoms. Linking mental health with its underlying biology via genomics and machine learning shortens the diagnostic odyssey and creates timely and targeted interventions further upstream than today’s outdated tools.

INTRODUCING PTS-ID™

First-of-its-kind blood test for PTSD screening and triage

PTS-ID™ measures blood RNA expression levels of proprietary genetic markers highly correlated with HPA axis (fight-or-flight) dysregulation associated with PTSD. Using machine learning, PTS-ID™ is 2-3 times more sensitive to measures indicative of PTSD than current self-report measures alone.

Connect With Us

Together, let's blaze the way

Transforming the mental health landscape takes a village. At Polaris, we actively welcome collaborations with researchers and leadership across pharma, academic, clinical, CRO, government, and other neuropsychiatric partners.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*
Sign up*

Notifications